Andrew J. Einhorn, Chief Financial Officer at Edge Therapeutics, Inc. (EDGE), bought 64,748 shares at $11.00 ($524K) on 2015-10-06, disclosed to the SEC on 2015-10-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,720 | $0 | 0.0% |
| 2 | $6.79 | 2,377 | $16K | 3.1% |
| 3 | $7.75 | 1,651 | $13K | 2.4% |
| 4 | $11.00 | 45,000 | $495K | 94.5% |
| Total | $8.09 avg | 64,748 | $524K | 100% |